Courage over Cancer Filtered Blog
NIH grant to boost ovarian cancer drug development
The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.
Read moreBoosting Hispanic representation in cancer research
The Mays Cancer Center has been named a founding partner of the Advancing Inclusive Research Site Alliance, a coalition of clinical research sites seeking to advance the representation of diverse patient populations in clinical trials.
Read moreDisparities discussed at San Antonio Breast Cancer Symposium
Researchers from the Mays Cancer Center at UT Health San Antonio presented results of multiple lines of study during the San Antonio Breast Cancer Symposium, operated in conjunction with the American Association of Cancer Research.
Read moreCryo-EM technology brings the study of tumors to a molecular level
UT Health San Antonio is investing $5 million over the next three years in cryo-electron microscopy technology that will help investigators of the Mays Cancer Center study tumors and help researchers of the Greehey Children’s Cancer Research Institute to study childhood cancers.
Read moreNew discovery: Compounds that target enzyme, MAP4K3
Daruka Mahadevan, MD, PhD, division chief, hematology-oncology, director of the Institute of Drug Development and associate director for clinical research at Mays Cancer Center at UT Health San Antonio and his team have identified a series of small molecule compounds that target an enzyme, MAP4K3, important to amino acid signaling in autophagy, impacting neurologic diseases and cancer.
Read moreNew discoveries in pediatric cancer research
The findings from recent research studies in pediatric cancer offer hope for drug development.
Read moreFirst lady Jill Biden visits Mays Cancer Center
In February 2022, first lady Jill Biden toured the Mays Cancer Center at UT Health San Antonio and praised its efforts in addressing disparities in cancer rates among Hispanics.
Read moreCancer and sun safety: protecting your skin during summer months
Using sun protection every day is essential to keep your skin happy and healthy, but it becomes increasingly necessary during the summertime. Check out these tips to keep your skin safe this season.
Read moreMays Cancer Center awards and honors
A summary of several of the many awards and honors received by Mays Cancer Center and its researchers during Fiscal Year 2022.
Read moreA year of transformative progress
UT Health San Antonio's Joe R. and Teresa Lozano Long School of Medicine Dean Robert Hromas, MD, identifies four areas of focus of the Mays Cancer Center in its quest to end cancer for communities in South Texas and beyond.
Read morePromising compound kills range of hard-to-treat cancers
Ratna Vadlamudi, PhD, a professor of obstetrics and gynecology at the Mays Cancer Center, is researching compounds that can target cancer cells to stop their growth.
Read moreExploring technological advances in patient treatment
Mays Cancer Center is at the forefront of technology-assisted surgical treatments that are improving patient recovery.
Read more